Searched over 200M research papers
5 papers analyzed
These studies suggest that while statins are generally safe and effective with benefits outweighing the risks, the risk of side effects may increase with higher doses and in patients with multiple medical conditions, but they do not specify which statin has the least side effects.
20 papers analyzed
Statins, or hydroxymethyl glutaryl coenzyme A reductase inhibitors, are widely prescribed for lowering cholesterol and preventing cardiovascular diseases. Despite their benefits, concerns about their side effects persist. This article synthesizes research findings to identify which statin has the least side effects.
Muscle pain (myalgia) is the most common side effect, affecting 1-10% of users. Severe muscle damage (rhabdomyolysis) is rare, occurring in less than 0.1% of patients . The risk of muscle-related side effects varies among different statins and increases with higher doses and drug interactions.
Statins can cause asymptomatic increases in liver enzymes in 0.5-2% of patients, but these are generally not clinically significant. Severe liver injury is very rare . All statins can cause these enzyme elevations, but they do not typically lead to liver disease.
Statins are associated with a modest increase in the risk of new-onset diabetes, particularly in patients with metabolic syndrome or prediabetes. However, pitavastatin has not been linked to an increased risk of diabetes, making it a potentially safer option for patients concerned about this side effect.
Research indicates that statins do not adversely affect cognitive function, even at very low levels of low-density lipoprotein cholesterol.
Statins are not associated with clinically significant deterioration of renal function.
While statins are generally safe, rare side effects such as haemorrhagic stroke and cataracts have been reported. However, the evidence does not support a significant increase in these risks for most patients .
Overall, statins are safe and well-tolerated for the majority of patients. Among the various statins, pitavastatin stands out for its lower risk of diabetes, making it a preferable choice for patients at risk of this condition. The cardiovascular benefits of statins far outweigh the risks of adverse effects, and their use should be encouraged in appropriate patient groups with close monitoring for side effects .
Most relevant research papers on this topic